Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis

Cardiac-resynchronization therapy (CRT) reduces morbidity and mortality in patients with chronic systolic heart failure (SHF) and a wide QRS complex. It is unclear whether the same benefit extends to patients with QRS duration (QRSd)

Saved in:
Bibliographic Details
Published in:Europace (London, England) England), 2015-02, Vol.17 (2), p.267-273
Main Authors: Shah, Rachit M, Patel, Dhavalkumar, Molnar, Janos, Ellenbogen, Kenneth A, Koneru, Jayanthi N
Format: Article
Language:English
Subjects:
Cardiac Resynchronization Therapy - methods
Cardiac Resynchronization Therapy Devices
Death, Sudden, Cardiac - prevention & control
Defibrillators, Implantable
Heart Failure, Systolic - mortality
Heart Failure, Systolic - therapy
Hospitalization
Humans
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiac-resynchronization therapy (CRT) reduces morbidity and mortality in patients with chronic systolic heart failure (SHF) and a wide QRS complex. It is unclear whether the same benefit extends to patients with QRS duration (QRSd)
ISSN:1099-5129
1532-2092
DOI:10.1093/europace/euu214